netFormulary North Central London NHS
Joint Formulary  
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
02.11  Expand sub section  Antifibrinolytic drugs and haemostatics
02.11  Expand sub section  Blood-related products
Antithrombin III (Kybemin)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available through the haemophilia centre
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Factor IX
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available from the haemophilia centre
    • Alphanine®, Alprolix® (eftrenonacog alfa), Benefix® (nonacog alfa), Idelvion® (albutrepenonacog alfa), Refixia® (nonacog beta pegol)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Factor VIIa, recombinant (Novo 7)
View adult BNF View SPC online View childrens BNF
Formulary
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available from the haemophilia centre
  • RNOH:
    • No restriction stated
  • UCLH:
  • WH:
    • Non-formulary

 

 
   
Factor VIII
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • PbR (Payment by Results) excluded drug
  • RFL:
    • Available from the Haemophilia centre
    • Advate® (octocog alfa), Elocta® (efmoroctocog alfa), Fanhdi®, Fibrogammin®, Helixate Nexgen® (octocog alfa), Kogenate® (octocog alfa), Novoeight®, Optivate®, Refacto AF® (moroctocog alfa)
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Factor VIII Inhibitor Bypassing Fraction
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available through the haemophilia centre
    • Feiba®
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Factor X (Coagadex)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available from the haemphilia centre
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Human fibrinogen (Riastap)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available through the haemophilia centre
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Prothrombin Complex Concentrate  (Octaplex)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • PbR (Payment by Results) excluded drug. For rapid reversal of anticoagulation in life-threatening bleeding due to oral anticoagulation. To be administered with 5mg of intravenous vitamin K.
  • RFL:
    • Available from the haemophilia centre.
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
Factor XI (Hemoleven)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
High Cost Medicine
AAAAAAAA

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Available from the Haemphilia centre
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
   
 ....
 Non Formulary Items
Drotrecogin alfa  (Xigris)

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Factor XIII Fraction, Dried

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine
 
Fresh Frozen Plasma

View adult BNF View SPC online View childrens BNF
Non Formulary
 
Protein C Concentrate  (Ceprotin)

View adult BNF View SPC online View childrens BNF
Non Formulary
High Cost Medicine

Provider notes

  • NMUH:
    • Non-formulary
  • RFL:
    • Non-formulary
  • RNOH:
    • Non-formulary
  • UCLH:
  • WH:
    • Non-formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

GP - 1st

Medicines suitable for first-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - 2nd

Medicines suitable for second-line use within primary care.

Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.

  

GP - Amber

Medicines that should be initiated by a specialist. Prescribing can be transferred to primary care once the patient has been stabilised.

Shared care: For drugs with regular, ongoing need for monitoring and/or assessment of efficacy or toxicity. Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the North Central London JFC.

Fact sheet: For drugs with some concerns surrounding safety or efficacy but do not require regular monitoring and/or monitoring of effectiveness/toxicity.

  

GP - Red

Medicines which should normally be prescribed by specialists only (hospital only).

For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

  

GP - Grey

Medicines on hospital formularies which have not been reviewed for suitability in primary care.  

Black

Medicines not recommended for routine use in primary or secondary care.

Medicines, which the North Central London JFC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.

  

netFormulary